Crossref
journal-article
Elsevier BV
Brain Research Reviews (78)
References
80
Referenced
126
10.1016/0092-8674(92)90546-O
/ Cell / The MARCKS brothers: a family of protein kinase C substrates by Aderem (1992)10.1016/S0304-3940(02)00332-4
/ Neurosci. Lett. / An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells by Akao (2002)10.1016/j.neulet.2003.10.067
/ Neurosci. Lett. / Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline by Bar-Am (2004)10.1111/j.1471-4159.2004.02425.x
/ J. Neurochem. / Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo by Bar-Am (2004)10.1016/S0166-2236(97)01084-9
/ Trends Neurosci. / The role of anchoring protein RACK1 in PKC activation in the ageing rat brain by Battaini (1997)10.1006/exnr.1999.7151
/ Exp. Neurol. / Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients by Battaini (1999)10.1016/S0304-3940(97)00894-X
/ Neurosci. Lett. / Specific role for protein kinase C alpha in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts by Benussi (1998)10.1016/S0021-9258(18)53878-3
/ J. Biol. Chem. / The MARCKS family of cellular protein kinase C substrates by Blackshear (1993)10.1073/pnas.87.15.6003
/ Proc. Natl. Acad. Sci. U. S. A. / Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation by Buxbaum (1990)10.1046/j.1471-4159.1997.68062523.x
/ J. Neurochem. / Increased secretion of the amino-terminal fragment of amyloid precursor protein in brains of rats with a constitutive up-regulation of protein kinase C by Caputi (1997)10.1016/S0165-0173(98)00046-0
/ Brain Res., Brain Res. Rev. / An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration by Cassarino (1999)10.1097/01.nrl.0000087724.73783.5f
/ Neurologist / Update on rivastigmine by Farlow (2003)10.1097/00001756-199803090-00026
/ NeuroReport / Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor by Finberg (1998)10.1016/j.jneuroim.2004.01.004
/ J. Neuroimmunol. / A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis by Furlan (2004)10.1016/S0006-2952(97)00155-X
/ Biochem. Pharmacol. / Protective effects of tea polyphenols against oxidative damage to red blood cells by Grinberg (1997)10.1007/s00702-003-0030-x
/ J. Neural Transm. / Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease by Grunblatt (2004){'key': '10.1016/j.brainresrev.2004.12.027_bib17', 'first-page': '271', 'article-title': 'Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro study', 'volume': '45', 'author': 'Gsell', 'year': '1995', 'journal-title': 'J. Neural Transm., Suppl.'}
/ J. Neural Transm., Suppl. / Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro study by Gsell (1995)10.1016/S0005-2760(96)00122-1
/ Biochim. Biophys. Acta / Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes by Guo (1996)10.1073/pnas.83.8.2353
/ Proc. Natl. Acad. Sci. U. S. A. / Protein kinase C as a component of a nerve growth factor-sensitive phosphorylation system in PC12 cells by Hama (1986)10.1016/S0014-2999(98)00929-7
/ Eur. J. Pharmacol. / Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse by Huang (1999){'key': '10.1016/j.brainresrev.2004.12.027_bib21', 'first-page': '1', 'article-title': "Post mortem studies in Parkinson's disease—is it possible to detect brain areas for specific symptoms?", 'author': 'Jellinger', 'year': '1991', 'journal-title': 'J. Neural Transm., Suppl.'}
/ J. Neural Transm., Suppl. / Post mortem studies in Parkinson's disease—is it possible to detect brain areas for specific symptoms? by Jellinger (1991)10.2165/00002512-199506020-00006
/ Drugs Aging / Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy by Jin (1995)10.1097/00001756-200003200-00042
/ NeuroReport / Phosphorylation of MARCKS in Alzheimer disease brains by Kimura (2000)10.1016/0014-5793(95)00392-M
/ FEBS Lett. / Conventional protein kinase C (PKC)-alpha and novel PKC epsilon, but not -delta, increase the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts by Kinouchi (1995)10.1152/ajpcell.1993.265.4.C939
/ Am. J. Physiol. / AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C by Kribben (1993)10.1271/bbb.65.126
/ Biosci. Biotechnol. Biochem. / Effects of pH and metal ions on antioxidative activities of catechins by Kumamoto (2001)10.1046/j.1471-4159.2001.00490.x
/ J. Neurochem. / Green tea polyphenol (−)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration by Levites (2001)10.1074/jbc.M202832200
/ J. Biol. Chem. / Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (−)-epigallocatechin-3-gallate neuroprotective action by Levites (2002)10.1073/pnas.96.21.12108
/ Proc. Natl. Acad. Sci. U. S. A. / Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation by Lin (1999)10.1523/JNEUROSCI.21-09-02929.2001
/ J. Neurosci. / How protein kinase C activation protects nerve cells from oxidative stress-induced cell death by Maher (2001)10.1016/S0165-6147(03)00067-1
/ Trends Pharmacol. Sci. / Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs by Mandel (2003){'key': '10.1016/j.brainresrev.2004.12.027_bib32', 'first-page': '171', 'article-title': 'Neurotoxins induce apoptosis in dopamine neurons: protection by N- propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022', 'author': 'Maruyama', 'year': '2000', 'journal-title': 'J. Neural Transm., Suppl.'}
/ J. Neural Transm., Suppl. / Neurotoxins induce apoptosis in dopamine neurons: protection by N- propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022 by Maruyama (2000)10.1111/j.1749-6632.2001.tb03641.x
/ Ann. N. Y. Acad. Sci. / Antiapoptotic function of N-propargylamine-1(R)- and (S)-aminoindan, Rasagiline and TV1022 by Maruyama (2000)10.1046/j.1471-4159.2001.00448.x
/ J. Neurochem. / Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3 phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol by Maruyama (2001)10.1007/s007020170093
/ J. Neural Transm. / Enantio-specific induction of apoptosis by an endogenous neurotoxin, N- methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine by Maruyama (2001)10.1523/JNEUROSCI.11-09-02759.1991
/ J. Neurosci. / Protein kinase C alteration is an early biochemical marker in Alzheimer's disease by Masliah (1991)10.1046/j.1471-4159.1996.67010317.x
/ J. Neurochem. / Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease by Matsushima (1996){'key': '10.1016/j.brainresrev.2004.12.027_bib38', 'first-page': '337', 'article-title': 'Distribution of the protein kinase C substrates MARCKS and MRP in the postnatal developing rat brain', 'volume': '397', 'author': 'McNamara', 'year': '1998', 'journal-title': 'J. Neurol.'}
/ J. Neurol. / Distribution of the protein kinase C substrates MARCKS and MRP in the postnatal developing rat brain by McNamara (1998)10.1073/pnas.95.24.14517
/ Proc. Natl. Acad. Sci. U. S. A. / Effect of reduced myristoylated alanine-rich C kinase substrate expression on hippocampal mossy fiber development and spatial learning in mutant mice: transgenic rescue and interactions with gene background by McNamara (1998)10.1046/j.1471-4159.1999.0720443.x
/ J. Neurochem. / Regulation of amyloid precursor protein cleavage by Mills (1999)10.1126/science.7716516
/ Science / Localization of protein kinases by anchoring proteins: a theme in signal transduction by Mochly-Rosen (1995)10.1016/0165-3806(85)90015-X
/ Brain Res. / Tumor-promoting phorbol diester mimics two distinct neuronotrophic factors by Montz (1985)10.1046/j.1471-4159.1994.63062179.x
/ J. Neurochem. / Cortical cytochrome oxidase activity is reduced in Alzheimer's disease by Mutisya (1994)10.1016/S1353-8020(01)00028-1
/ Parkinsonism Relat. Disord. / Future of neuroprotection in Parkinson's disease by Naoi (2001)10.1038/334661a0
/ Nature / The molecular heterogeneity of protein kinase C and its implications for cellular regulation by Nishizuka (1988)10.1126/science.1411529
/ Science / Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors by Nitsch (1992)10.1056/NEJM198905183202007
/ N. Engl. J. Med. / A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy by Parker (1989)10.1080/10715760310001643311
/ Free Radic. Res. / Mitochondrial respiratory chain dysfunction in ageing; influence of vitamin E deficiency by Rafique (2004)10.2174/1389450043345272
/ Curr. Drug Targets / Metal and inflammatory targets for Alzheimer's disease by Rogers (2004)10.1111/j.1460-9568.1997.tb01379.x
/ Eur. J. Neurosci. / In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity by Rossner (1997)10.1016/0166-2236(95)93902-A
/ Trends Neurosci. / Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging by Roth (1995)10.1074/jbc.273.39.25436
/ J. Biol. Chem. / A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis by Ruvolo (1998)10.1046/j.1471-4159.2003.01801.x
/ J. Neurochem. / Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor by Sagi (2003)10.1111/j.1749-6632.1993.tb23023.x
/ Ann. N. Y. Acad. Sci. / Hyperactivation of signal transduction systems in Alzheimer's disease by Saitoh (1993)10.1016/0306-4522(94)90311-5
/ Neuroscience / Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography by Saura (1994)10.1212/WNL.43.7.1407
/ Neurology / Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease by Shimohama (1993)10.1016/S0021-9258(19)36898-X
/ J. Biol. Chem. / Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase C alpha by Slack (1993)10.1021/jm020120c
/ J. Med. Chem. / Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease by Sterling (2002)10.1001/archneur.59.12.1937
/ Arch. Neurol. / A controlled trial of rasagiline in early Parkinson disease (2002)10.1001/archneur.61.4.561
/ Arch. Neurol. / A control randomized delayed start study of rasagiline in early Parkinson's disease (2004)10.1016/S0014-5793(99)01761-5
/ FEBS Lett. / Bcl-2 family: life-or-death switch by Tsujimoto (2000)10.1007/s002130000396
/ Psychopharmacology (Berl) / Pharmacological demonstration of the differential involvement of protein kinase C isoforms in short- and long-term memory formation and retrieval of one-trial avoidance in rats by Vianna (2000)10.1016/0197-4580(94)90023-X
/ Neurobiol. Aging / Attenuated protein kinase C activity and translocation in Alzheimer's disease brain by Wang (1994)10.1096/fj.04-1916fje
/ FASEB J. / Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members by Weinreb (2004){'issue': 'Suppl. 60', 'key': '10.1016/j.brainresrev.2004.12.027_bib65', 'first-page': 'S157', 'article-title': "TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease", 'author': 'Weinstock', 'year': '2000', 'journal-title': 'J. Neural Transm.'}
/ J. Neural Transm. / TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease by Weinstock (2000)10.1111/j.1749-6632.2001.tb03622.x
/ Ann. N. Y. Acad. Sci. / Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs by Weinstock (2001)10.1007/s00213-001-0978-x
/ Psychopharmacology (Berl) / Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression by Weinstock (2002)10.1016/S0278-5846(03)00053-8
/ Neuropsychopharmacol. Biol. Psychiatry / A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease by Weinstock (2003)10.1111/j.1471-4159.2004.02359.x
/ J. Neurochem. / Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid by Wenk (2004)10.1006/bbrc.2000.4181
/ Biochem. Biophys. Res. Commun. / Blockade of PKC epsilon activation attenuates phorbol ester-induced increase of alpha-secretase-derived secreted form of amyloid precursor protein by Yeon (2001)10.1096/fj.02-0198fje
/ FASEB J. / The involvement of mitogen-activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline by Yogev-Falach (2002)10.1096/fj.03-0078fje
/ FASEB J. / The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives for MAPK-dependent amyloid precursor protein processing by Yogev-Falach (2003)10.1586/14737175.3.6.737
/ Expert Rev. Neurotherapeutics / Rasagiline: an anti-Parkinson drug with neuroprotective activity by Youdim (2003)10.1023/A:1015131516649
/ Cell. Mol. Neurobiol. / Molecular basis of neuroprotective activities of rasagiline and the anti Alzheimer drug, TV3326, [(N-Propargyl-(3R)Aminoindan-5-YL)-Ethyl Methyl Carbamate] by Youdim (2002)10.1038/sj.bjp.0703826
/ Br. J. Pharmacol. / Rasagiline [N-Propargyl-1R(+)-aminoindant], a selective and potent inhibitor of mitochondrial monoamine oxidase B by Youdim (2001)10.1111/j.1749-6632.2001.tb03656.x
/ Ann. N. Y. Acad. Sci. / The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo by Youdim (2001)10.1016/S0006-2952(03)00535-5
/ Biochem. Pharmacol. / The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline by Youdim (2003){'key': '10.1016/j.brainresrev.2004.12.027_bib78', 'first-page': '1', 'article-title': "Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases", 'author': 'Youdim', 'year': '2004', 'journal-title': 'J. Neural Transm.'}
/ J. Neural Transm. / Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases by Youdim (2004)10.1196/annals.1306.025
/ Ann. N. Y. Acad. Sci. / Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28 by Youdim (2004)10.1038/nrn1537
/ Nat. Rev. Neurosci. / Iron, brain ageing and neurodegenerative disorders by Zecca (2004)
Dates
Type | When |
---|---|
Created | 20 years, 4 months ago (April 4, 2005, 9:29 a.m.) |
Deposited | 1 year, 7 months ago (Jan. 24, 2024, 10:50 a.m.) |
Indexed | 1 month, 2 weeks ago (July 11, 2025, 6:16 a.m.) |
Issued | 20 years, 4 months ago (April 1, 2005) |
Published | 20 years, 4 months ago (April 1, 2005) |
Published Print | 20 years, 4 months ago (April 1, 2005) |
@article{Mandel_2005, title={Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives}, volume={48}, ISSN={0165-0173}, url={http://dx.doi.org/10.1016/j.brainresrev.2004.12.027}, DOI={10.1016/j.brainresrev.2004.12.027}, number={2}, journal={Brain Research Reviews}, publisher={Elsevier BV}, author={Mandel, Silvia and Weinreb, Orly and Amit, Tamar and Youdim, Moussa B.H.}, year={2005}, month=apr, pages={379–387} }